Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

AstraZeneca R&D Mölndal

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rémi Rabasa-Lhoret

Institut de Recherches Cliniques de Montreal

Moderately Similar
16 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score30%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Moderately Similar
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score30%

Roman Hovorka, PhD

University of Cambridge

Moderately Similar
13 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score30%

Lisa Porter, MD

Amylin Pharmaceuticals, LLC.

Moderately Similar
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

AstraZeneca
Similarity Score30%

Samuel Klein, MD

Washington University School of Medicine

Moderately Similar
30 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score30%

Bruce Bode, MD

Atlanta Diabetes Associates

Moderately Similar
8 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score30%

Timothy Bailey, MD

AMCR Institute

Moderately Similar
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score30%

Adrian Vella, MD

Mayo Clinic

Moderately Similar
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score30%

Mustafa H Temel, M.D.

Uskudar State Hospital

Moderately Similar
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score30%

Linda Morrow, MD

Profil Institute for Clinical Research, Inc.

Related
6 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00790153Phase 1StudyDirector

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

Type 2 Diabetes
Completed
NCT00817505Phase 1StudyDirector

To Evaluate the Bioavailability of a Tablet of AZD1656

Type 1 Diabetes
Completed
NCT00817778Phase 2StudyDirector

Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Type 2 Diabetes
Completed

All 3 trials loaded